Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
- 1 May 2020
- journal article
- letter
- Published by Elsevier BV in Annals of Oncology
- Vol. 31 (8), 1087-1088
- https://doi.org/10.1016/j.annonc.2020.04.475
Abstract
No abstract availableFunding Information
- Inca (INCA-DGOS-INSERM 12563)
- DGOS
- Inca
- DGOS
- Inca
- DGOS
- Fondation ARC (FP7-278742)
- Inca (ANR-10-LABX 0061)
This publication has 5 references indexed in Scilit:
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology, 2020
- Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19mBio, 2020
- In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging TrendsDiagnostics, 2020
- Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19Journal of Medical Virology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020